Condition
Hyperalgesia, Secondary
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04220697Not ApplicableUnknown
Central Sensitisation and Postoperative Pain
NCT03966508Not ApplicableCompletedPrimary
Reliability of Measuring the Area and Intensity of Secondary Hyperalgesia Induced by High Frequency Stimulation
NCT01015807Not ApplicableCompletedPrimary
Transversus Abdominis Plane (TAP) Block for Cesarean Section
NCT00561782Completed
MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI
NCT00785863Phase 4CompletedPrimary
Modulation of Remifentanil-induced Postinfusion Hyperalgesia
Showing all 5 trials